NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









AerWave Medical

AerWave Medical

Private
New York City, New YorkHealthcare & Life Scienceshttps://aerwavemed.com/

Last Round

Early Funding

Jan 8, 2025

Total Funding Raised

$21M

Company Overview

AerWave Medical is a medical device company developing an interventional ultrasound therapy platform for the treatment of pulmonary diseases such as asthma and chronic obstructive pulmonary disease (COPD).

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials, Health IoT, Sensors

Business Model

B2B

Customer Profile

Hardware + Subscription, Hardware Sales, Government Contracts

AI Layer

Non-AI

Keywords

neuromodulationvagus nerve stimulationVNSwearable medical devicebioelectronic medicineCOPD treatmentChronic Obstructive Pulmonary DiseaseCOPDasthma treatmentrespiratory disease treatmentdrug-free treatmentnon-invasive treatmentsmart patchinhaler alternativerazor-razorblade modelmedical consumablesclinical-stage device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

AerWave Medical Comparables

Compare AerWave Medical with similar companies based on industry and business-model similarity.

AerWave Medical comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Spiro Medical
72%
ResMed Inc
62%
Teva Pharmaceuticals
61%

AerWave Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingJan 8, 2025
DebtMay 1, 2024
Series AFeb 24, 2021

AerWave Medical Investors

Notable investors and investment history

AerWave Medical investors
InvestorRounds
Lucius PartnersEarly Funding
Long Island High Technology IncubatorSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 8, 2025

    $12M raised, led by Lucius Partners.

  • May 1, 2024

    $5M raised in debt financing.

AerWave Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

AerWave Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about AerWave Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersNew York City, New York
Year Founded2020
Last FundingJan 8, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.